rs771641910
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001024383.2(NAV3):c.605G>A(p.Arg202Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000211 in 1,613,956 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001024383.2 missense
Scores
Clinical Significance
Conservation
Publications
- complex neurodevelopmental disorderInheritance: AR Classification: DEFINITIVE Submitted by: Ambry Genetics
- neurodevelopmental disorderInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152142Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000241 AC: 6AN: 249302 AF XY: 0.0000222 show subpopulations
GnomAD4 exome AF: 0.0000212 AC: 31AN: 1461814Hom.: 0 Cov.: 31 AF XY: 0.0000165 AC XY: 12AN XY: 727202 show subpopulations
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152142Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74322 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.605G>A (p.R202Q) alteration is located in exon 5 (coding exon 5) of the NAV3 gene. This alteration results from a G to A substitution at nucleotide position 605, causing the arginine (R) at amino acid position 202 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at